Efficacy of immunosuppressants with bridge vasodilator therapy in severe lupus erythematosus‐associated pulmonary arterial hypertension

Optimal management of systemic lupus erythematosus (SLE)‐associated pulmonary arterial hypertension (PAH) remains unclear. Our observation describes the case of a 31‐year‐old SLE patient presenting with cardiogenic shock revealing severe PAH, in which a therapeutic scheme combining immunosuppressant...

Descripción completa

Detalles Bibliográficos
Autores principales: Sanges, Sébastien, Savale, Laurent, Lamblin, Nicolas, Rémy‐Jardin, Martine, Humbert, Marc, Sobanski, Vincent
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6989275/
https://www.ncbi.nlm.nih.gov/pubmed/31536678
http://dx.doi.org/10.1002/ehf2.12507

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6989275/
https://www.ncbi.nlm.nih.gov/pubmed/31536678
http://dx.doi.org/10.1002/ehf2.12507

Ejemplares similares